SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ROTC:Rotech medical

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bryce Elkins who wrote (156)10/3/1997 7:28:00 PM
From: David Lawrence   of 161
 
Some excerpts from the Value Line report.....

1. Combined company revenies >$2.3 billion.
2. 975 home-health locations
3. 1500 post-acute offices in 43 states
4. Very diversified - more attractive to managed care payors
5. Expect shareholder approval will occur on 10/17
6. If occurs, closing should occur by EOM.
7. Home care market still ripe for consolidation.
8. Combined entity will be able to find many affordable acquisitions
9. Even a 25% reduction in medicare-oxy, minimal effect on bottom line

"The union with IHS should be a net positive for Rotech shareholders. We expect the merger to be immediately accretive to IHS's earnings, as well as an enhancement to its balance sheet. (No shit) Furthermore, as part of a larger company. RoTech's skill at acquiring and integrating small home-care operations will be better recognized by the market. Therefore, we do not recommend RoTech shareholders sell their shares on the open market."

Source: 10/03/97 Value Line

Well, there is one man's opinion, anyway.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext